In this new role, Dr. Bernstein will support the company’s efforts to bring Remimazolam to the U.S. market. Remimazolam is an ultra-short-acting anesthetic.
Dr. Bernstein also serves as the director of the Center for Liver Diseases at North Shore LIJ Health System and professor of medicine at Hofstra North Shore LIJ School of Medicine.
More articles on gastroenterology:
What qualities should young GI physicians look for in a mentor?
GI physician leader to know: Dr. Gary Lichtenstein of Penn Medicine
ASGE recognizes Exeter Hospital: 4 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
